| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.56.11.1533 |
| P698 | PubMed publication ID | 11402111 |
| P50 | author | Peter R Schofield | Q39700435 |
| P2093 | author name string | Smith M | |
| Masters CL | |||
| Schofield PR | |||
| Collie A | |||
| Maruff P | |||
| Currie J | |||
| Hallup M | |||
| Shafiq-Antonacci R | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mild cognitive impairment | Q1472703 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1533-1538 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Memory decline in healthy older people: implications for identifying mild cognitive impairment. | |
| P478 | volume | 56 |
| Q30684599 | An analysis of systems of classifying mild cognitive impairment in older people. |
| Q46089144 | Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults |
| Q45054674 | Apolipoprotein E genotype and lifetime cognitive decline. |
| Q48552163 | Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. |
| Q33608563 | Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia |
| Q34688023 | Apolipoproteins and aging: emerging mechanisms |
| Q35995579 | Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sample |
| Q38059910 | Cognitive decline in older adults with a history of traumatic brain injury |
| Q35147752 | Cognitive function in a general population of men and women: a cross sectional study in the European Investigation of Cancer-Norfolk cohort (EPIC-Norfolk). |
| Q93629910 | Commentary |
| Q34386582 | Computerised cognitive assessment of athletes with sports related head injury |
| Q37681245 | Contemporary review 2009: cognitive aging |
| Q50886837 | Decline in verbal memory in non-demented older adults. |
| Q47903418 | Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial |
| Q35019320 | Genetic variation in memory functioning |
| Q40183680 | Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion |
| Q51897976 | Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease? |
| Q35992695 | Learning and generalization in healthy aging: implication for frontostriatal and hippocampal function |
| Q51980686 | Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease. |
| Q34509732 | Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease |
| Q33899689 | Predicting the time of conversion to MCI in the elderly: role of verbal expression and learning |
| Q45801990 | Predictors of cognitive decline in 85-year-old patients without cognitive impairment at baseline: 2-year follow-up of the octabaix study. |
| Q36110122 | Relations between Concurrent Longitudinal Changes in Cognition, Depressive Symptoms, Self-Rated Health and Everyday Function in Normally Aging Octogenarians. |
| Q36177038 | Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia |
| Q34177636 | Saccade and cognitive function in chronic kava users. |
| Q48624137 | Selectively impaired associative learning in older people with cognitive decline |
| Q45021886 | Subtle memory decline over 12 months in mild cognitive impairment. |
| Q37239001 | The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias |
| Q33593198 | The utility of placing recollection in opposition to familiarity in early discrimination of healthy aging and very mild dementia of the Alzheimer's type |
| Q58698507 | Understanding the relationship between cognition and death: a within cohort examination of cognitive measures and mortality |
| Q37863247 | Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease. |
| Q31005081 | Variable selection in a flexible parametric mixture cure model with interval-censored data |
Search more.